PCRX

Pacira BioSciences, Inc.

Pharmaceuticals · Pharmaceuticals

$129.10 sample

-1.57 (-1.20%) 1D

Market cap

$234.8B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-01

Alerts

8

Price$129.10 +7.05% 3M daily closessample

131.01118.99

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider buy: Chief Financial Officer
Sep 24INSInsider buy: Director
Sep 18INSInsider buy: Director
Sep 14INSInsider buy: Chief Financial Officer
Sep 07INSInsider sell: Chief Executive Officer
Sep 01SECDEF 14A filed
Aug 26INSInsider sell: Chief Executive Officer
Aug 17INSInsider buy: EVP, Operations

Sign up to see the real PCRX record →

Company facts

SEC EDGAR registration

Name: Pacira BioSciences, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +6sample, -100 to +100
Reporting currency: USD

Who is positioning in PCRX

sample

Insiders: 14 insider transactions over 90 days, net selling, $286.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 12 funds hold $2.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.0B +15.9% y/y

Q4 2024Q3 2026

Inventory$9.3B +12.7% y/y

Q4 2024Q3 2026

Accounts receivable$6.7B +4.1% y/y

Q4 2024Q3 2026

Total debt$19.2B +20.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $103.4B +0.4% 3M
Sample peer B: $38.2B +11.1% 3M
Sample peer C: $141.2B -2.5% 3M
Sample peer D: $128.7B +3.0% 3M
Sample peer E: $171.1B +11.4% 3M